Sequence types 235, 111, and 132 predominate among multidrug-resistant pseudomonas aeruginosa clinical isolates in Croatia. - Wikidata - wikimedia - TriplyDB

Sequence types 235, 111, and 132 predominate among multidrug-resistant pseudomonas aeruginosa clinical isolates in Croatia.

Sequence types 235, 111, and 132 predominate among multidrug-resistant pseudomonas aeruginosa clinical isolates in Croatia.

http://www.wikidata.org/entity/Q34298890

about

Persistence and epidemic propagation of a Pseudomonas aeruginosa sequence type 235 clone harboring an IS26 composite transposon carrying the blaIMP-1 integron in Hiroshima, Japan, 2005 to 2012 Diversity of Molecular Mechanisms Conferring Carbapenem Resistance to Pseudomonas aeruginosa Isolates from Saudi Arabia.Genomics and Susceptibility Profiles of Extensively Drug-Resistant (XDR) Pseudomonas aeruginosa from Spain.Applying a PCR-based open-reading frame typing method for easy genotyping and molecular epidemiological analysis of Pseudomonas aeruginosa.VIM-2-Producing Pseudomonas spp. in Uruguay: Sequence Types, Pulsotypes, and Class 1 Integrons Including New Variable Regions Featuring blaVIM-2 and blaGES-7.

P2860

Q35385287-F120BA1D-8BB1-4601-B5E1-A4D176DF7848 Q37202044-F6EDF63C-FED1-45EF-A19B-7064F251E97C Q40056971-CBA01040-9419-4975-AB74-7C86350325CF Q40237644-4E418265-385D-456D-8A80-CEEDD7E191F2 Q42334062-D4687269-7658-4C5B-9768-020F65246614

P2860

Sequence types 235, 111, and 132 predominate among multidrug-resistant pseudomonas aeruginosa clinical isolates in Croatia.

http://www.wikidata.org/entity/Q34298890

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Sequence types 235, 111, and 1 ...... clinical isolates in Croatia.

@ast

Sequence types 235, 111, and 1 ...... clinical isolates in Croatia.

@en

Sequence types 235, 111, and 1 ...... clinical isolates in Croatia.

@nl

type

label

Sequence types 235, 111, and 1 ...... clinical isolates in Croatia.

@ast

Sequence types 235, 111, and 1 ...... clinical isolates in Croatia.

@en

Sequence types 235, 111, and 1 ...... clinical isolates in Croatia.

@nl

prefLabel

Sequence types 235, 111, and 1 ...... clinical isolates in Croatia.

@ast

Sequence types 235, 111, and 1 ...... clinical isolates in Croatia.

@en

Sequence types 235, 111, and 1 ...... clinical isolates in Croatia.

@nl

P1433

Q34298890-6D42D37C-EAAA-4985-8569-59FCD4DBBA13

P1476

Q34298890-BDB30589-A820-4DDF-B6BF-98667BA922A5

P2093

Q34298890-300546B5-E545-4698-9AA6-1365F981EA17

Q34298890-33DBFB50-0A70-4B92-98F5-14E28DAC3F14

Q34298890-59A33407-F116-415D-A1AF-AB023ABC2291

Q34298890-5B3EE670-4A9B-4F6F-8756-D2839FF0FED2

Q34298890-9A42591E-B187-4C37-9E10-CC0960723A68

Q34298890-9F7B89C1-0584-4B73-8C40-4622362A75D3

Q34298890-E8F1E458-6AAA-4948-875E-63EFE07F4D09

P2860

Q34298890-00A561D2-9545-49B7-9F0D-9CE4E118D2E8

Q34298890-0D255B0D-A04F-4EC3-9E56-FE4F6D6A550C

Q34298890-103EC0C4-3067-4D81-8B43-976952FBCF5F

Q34298890-178C039C-BAD3-4FB9-8FE0-56DE689F2B1A

Q34298890-29BAF546-68D4-4875-94E1-E5829997ADA0

Q34298890-2F42511D-4D02-4AB7-B6A1-566E5BD730E8

Q34298890-399755B2-BADE-4A23-8AC3-F4C0DB31D083

Q34298890-3A1D8221-A0EA-4332-9D59-26C126AD3515

Q34298890-3EFACDA3-A312-4F55-8874-EF41847B3719

Q34298890-487C2630-06E1-4F1E-B3C9-40AABF1701CF

P304

Q34298890-9688227F-075B-499F-A38A-02095F3D22D0

P31

Q34298890-D05D8D14-1AA5-46C8-BA1D-40DF5A965E91

P356

Q34298890-CB48C742-74E4-4777-8205-59B3FD2E1089

P407

Q34298890-00E5458A-4F93-45F9-AF2A-D8BA7E2CA06F

P433

Q34298890-706D6650-D02E-4819-B064-7F83B826629A

P478

Q34298890-3143AF6A-C1D3-44B5-87E2-D21B015CD9A9

P50

Q34298890-370E652C-42B3-4CFA-BF9A-218FAA7E9521

Q34298890-6138B6A4-DF18-4E0E-BBCF-581B9738FADA

Q34298890-F9370866-C252-4E95-BF2B-47CBD48E3F65

P577

Q34298890-B9B2FF6A-62BF-4228-B752-E1E35B11A0A7

P698

Q34298890-F18E0B02-7922-4730-841A-6B28C20AAC39

P921

Q34298890-291594A2-BAC0-479C-9DDA-4C1BE18C4286

P932

Q34298890-5AA8C8FE-5626-4282-96BE-036AECFF98EE

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Sequence types 235, 111, and 1 ...... a clinical isolates in Croatia

@en

P2093

Arjana Tambic Andrasevic

http://www.w3.org/2001/XMLSchema#string

Iva Butic

http://www.w3.org/2001/XMLSchema#string

Iva Koscak

http://www.w3.org/2001/XMLSchema#string

Marek Gniadkowski

http://www.w3.org/2001/XMLSchema#string

Marko Jelic

http://www.w3.org/2001/XMLSchema#string

Radosław Izdebski

http://www.w3.org/2001/XMLSchema#string

Waleria Hryniewicz

http://www.w3.org/2001/XMLSchema#string

P2860

Surveillance for antimicrobial resistance in Croatia

Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing

Metallo-beta-lactamases: the quiet before the storm?

Genetic environment and expression of the extended-spectrum beta-lactamase blaPER-1 gene in gram-negative bacteria.

Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance.

Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii

Population structure of Pseudomonas aeruginosa from five Mediterranean countries: evidence for frequent recombination and epidemic occurrence of CC235.

Molecular epidemiology of acquired-metallo-beta-lactamase-producing bacteria in Poland

Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study.

Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.

P304

6277-6283

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.03116-14

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

Marija Guzvinec

P577

2014-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25070098

http://www.w3.org/2001/XMLSchema#string

P921

multiple drug resistance

P932

4187922

http://www.w3.org/2001/XMLSchema#string